These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 34295393)

  • 1. Length of remdesivir treatment in patients with severe COVID-19.
    Ippolito M; Cortegiani A
    Breathe (Sheff); 2021 Mar; 17(1):200276. PubMed ID: 34295393
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis.
    Bansal V; Mahapure KS; Bhurwal A; Gupta I; Hassanain S; Makadia J; Madas N; Armaly P; Singh R; Mehra I; O'Horo JC; Kashyap R
    Front Med (Lausanne); 2020; 7():606429. PubMed ID: 33585508
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Virus Res; 2020 Oct; 288():198137. PubMed ID: 32827627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.
    Saroyo YB; Rumondang A; Febriana IS; Harzif AK; Irwinda R
    Infect Dis Rep; 2021 May; 13(2):437-443. PubMed ID: 34067822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis.
    Sarfraz A; Sarfraz Z; Sanchez-Gonzalez M; Michel J; Michel G; Frontela O; Posada J; Cardona J; Angueira E
    Turk J Emerg Med; 2021; 21(2):43-50. PubMed ID: 33969238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital length of stay for severe COVID-19: implications for Remdesivir's value.
    Anderson M; Bach P; Baldwin MR
    medRxiv; 2020 Aug; ():. PubMed ID: 32817960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
    Aleem A; Mahadevaiah G; Shariff N; Kothadia JP
    Proc (Bayl Univ Med Cent); 2021 Mar; 34(4):473-477. PubMed ID: 34219928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.
    Barkas F; Styla CP; Bechlioulis A; Milionis H; Liberopoulos E
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33673216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary rehabilitation in long COVID: more than just natural recovery!?
    Gloeckl R; Leitl D; Jarosch I; Schneeberger T; Nell C; Stenzel N; Daher A; Dreher M; Vogelmeier CF; Kenn K; Koczulla AR
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34471633
    [No Abstract]   [Full Text] [Related]  

  • 15. Does inflammation help during COVID-19?
    Sharma L; Chang D; Dela Cruz CS
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33083436
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to: Lung pathophysiology in patients with long COVID-19: one size definitely does not fit all.
    Barisione G; Brusasco V
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37529636
    [No Abstract]   [Full Text] [Related]  

  • 17. Puzzling persisting symptoms after COVID-19.
    Hellemons ME
    ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35449757
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious disease in respiratory medicine.
    Kent BD
    Breathe (Sheff); 2022 Mar; 18(1):220022. PubMed ID: 35285607
    [No Abstract]   [Full Text] [Related]  

  • 19. Discussing treatment burden.
    Powell P; Saggu R; Jones S; Clari M; Saraiva I; Hardavella G; Hansen K; Pinnock H
    Breathe (Sheff); 2021 Mar; 17(1):200284. PubMed ID: 34295397
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep medicine in Europe: 50 years of evolution.
    McNicholas WT
    Breathe (Sheff); 2022 Sep; 18(3):220206. PubMed ID: 36340826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.